Jefferies Maintains Buy on Haemonetics, Lowers Price Target to $85

Jefferies analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and lowers the price target from $105 to $85.

Jefferies analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and lowers the price target from $105 to $85.

Total
0
Shares
Related Posts